西亚试剂：Dissecting the Tumor Myeloid Compartment Reveals Rare Activ

Miranda L. Broz1, Mikhail Binnewies1, Bijan Boldajipour1, Amanda E. Nelson1, Joshua L. Pollack2, David J. Erle2, Andrea Barczak2, Michael D. Rosenblum3, Adil Daud4, Diane L. Barber5, Sebastian Amigorena7, Laura J. van’t Veer6, Anne I. Sperling8, Denise M. Wolf6, Matthew F. Krummel1.

It is well understood that antigen-presenting cells (APCs) within tumors typically do not maintain cytotoxic T cell (CTL) function, despite engaging them. Across multiple mouse tumor models and human tumor biopsies, we have delineated the intratumoral dendritic cell (DC) populations as distinct from macrophage populations. Within these, CD103+ DCs are extremely sparse and yet remarkably capable CTL stimulators. These are uniquely dependent on IRF8, Zbtb46, and Batf3 transcription factors and are generated by GM-CSF and FTL3L cytokines. Regressing tumors have higher proportions of these cells, T-cell-dependent immune clearance relies on them, and abundance of their transcripts in human tumors correlates with clinical outcome. This cell type presents opportunities for prognostic and therapeutic approaches across multiple cancer types

以上资料由西亚试剂：http://www.xiyashiji.com/ 提供